Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Will Novel Catheter Based Approaches Save the Day?

Presenter: Jaffar Khan

February 11, 2025

Presentation THT 2025

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Presenter: Hiroo Takayama

February 11, 2025

Presentation THT 2025

Gene Therapy for HCM: Is a Cure Coming?

Presenter: Nosheen Reza

February 11, 2025

Presentation THT 2025

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Presenter: Martin Maron

February 11, 2025

Presentation THT 2025

Case-in-the-Box: SESAME

Presenter: Adam Greenbaum

February 11, 2025

Presentation THT 2025

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Presenter: Anjali Owens

February 11, 2025

Presentation THT 2024

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Presenter: Adam B. Greenbaum

March 05, 2024

Presentation THT 2024

Transcather Approaches to HOCM: From ASA to SESAME

Presenter: Adam B. Greenbaum

March 04, 2024

Presentation THT 2024

Surgical Management of HOCM

Presenter: Hiroo Takayama

March 04, 2024

Presentation THT 2024

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

Presenter: Ahmad Masri

March 04, 2024

Presentation THT 2024

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

Presenter: Carolyn Ho

March 04, 2024

Presentation THT 2024

Multimodality Imaging to Phenotype HCM

Presenter: Martin Maron

March 04, 2024

Presentation THT 2024

KEYNOTE: The Spectrum of HCM – Lessons From a Half-Century Journey

Presenter: Christine Seidman

March 04, 2024

Advertisement

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Will Novel Catheter Based Approaches Save the Day?

Surgical Myectomy: Still the Gold Standard for Obstructive HCM?

Gene Therapy for HCM: Is a Cure Coming?

Current Evidence for Cardiac Myosin Inhibitors: Where Are We in 2025?

Case-in-the-Box: SESAME

Are We Ever Going to Have New Medical Therapy Options for Nonobstructive HCM?

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Transcather Approaches to HOCM: From ASA to SESAME

Surgical Management of HOCM

Cardiac Myosin Inhibitors as a Novel Treatment Option for Nonobstructive Hypertrophic Cardiomyopathy

HCM Genetics- Prognostic/Therapeutic Implications and Counseling

Multimodality Imaging to Phenotype HCM

KEYNOTE: The Spectrum of HCM – Lessons From a Half-Century Journey

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content